Claro Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,228
| Closed | -$208K | – | 429 |
|
|
2024
Q1 | $208K | Sell |
7,228
-609
| -8% | -$17.5K | 0.04% | 393 |
|
|
2023
Q4 | $257K | Buy |
7,837
+337
| +4% | +$11.1K | 0.06% | 314 |
|
|
2023
Q3 | $209K | Buy |
7,500
+982
| +15% | +$27.4K | 0.05% | 339 |
|
|
2023
Q2 | $222K | Buy |
+6,518
| New | +$222K | 0.06% | 329 |
|
|
2022
Q2 | – | Sell |
-9,962
| Closed | -$610K | – | 279 |
|
|
2022
Q1 | $610K | Hold |
9,962
| – | – | 0.22% | 124 |
|
|
2021
Q4 | $610K | Buy |
9,962
+1,318
| +15% | +$80.7K | 0.22% | 124 |
|
|
2021
Q3 | $646K | Buy |
8,644
+767
| +10% | +$57.3K | 0.27% | 103 |
|
|
2021
Q2 | $729K | Sell |
7,877
-709
| -8% | -$65.6K | 0.33% | 82 |
|
|
2021
Q1 | $762K | Buy |
8,586
+2,552
| +42% | +$226K | 0.39% | 70 |
|
|
2020
Q4 | $563K | Buy |
+6,034
| New | +$563K | 0.3% | 95 |
|